We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gentel Acquires SilverQuant Trademark from Eppendorf
News

Gentel Acquires SilverQuant Trademark from Eppendorf

Gentel Acquires SilverQuant Trademark from Eppendorf
News

Gentel Acquires SilverQuant Trademark from Eppendorf

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Gentel Acquires SilverQuant Trademark from Eppendorf"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

According to Dan Clutter, Gentel’s Vice President of Commercial Development, “The SilverQuant name accurately describes our unique chromogenic detection technology as well as its application to protein quantitation. Further, SilverQuant is a strong trademark that adds a valuable intangible asset to the Company given its worldwide registration and existing prestige in the life sciences.”

The acquisition of the SilverQuant trademark complements other Gentel initiatives to grow its position as an industry-leading provider of multiplexed proteomics tools. This strategy includes the launch of highly innovative SilverQuant antibody array products and services, the most sensitive and easy-to-use antibody arrays available in the market; and SilverQuant pathogen arrays for animal health surveillance, a product line that enables exceptional diagnostic accuracy.
Gentel acquired the rights to array-based chromogenic detection technology from Eppendorf in 2008 for use in protein detection assay applications. The patented method uses gold particle-enhanced silver crystal deposition for detection and quantification of arrays. SilverQuant detection works with the Gentel Proteomics Multi-System™, a complete array platform that integrates chromogenic scanning and analysis of arrays at a price that is comparable to that of a bench-top ELISA system.

“We are extremely excited by the early response to SilverQuant detection technology, particularly by valuable market segments such like animal health and clinical diagnostics, where high sensitivity and affordability are crucial to workflow,” said Alex Vodenlich, Gentel President and CEO.

Advertisement